A model with combined viral and metabolic factors effectively predicts HBeAg status under long term entecavir therapy: a prospective cohort study

BACKGROUND & AIM: The aim was to extract factors from virologic and biochemical profiles at baseline and 24 weeks of treatment to predict HBeAg seroconversion in patients treated with ETV. METHODS: HBeAg positive chronic hepatitis B patients receiving ETV naïve-treatment were enrolled. HBV DNA,...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fen, Zou, Feng, Wang, Xiwei, Hu, Huaidong, Hu, Peng, Ren, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630878/
https://www.ncbi.nlm.nih.gov/pubmed/26527281
http://dx.doi.org/10.1186/s12985-015-0409-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630878/
https://www.ncbi.nlm.nih.gov/pubmed/26527281
http://dx.doi.org/10.1186/s12985-015-0409-y

Ejemplares similares